Lymphocutaneous nocardiosis and cutaneous pheohyphomycosis in a liver transplant recipient.
BACKGROUND
Infections are the leading cause of morbidity and mortality in transplanted patients. The increasing number of immunocompromised patients has not only augmented infections by specific pathogens, but also by opportunistic microbial agents.


METHODS
A mixed cutaneous infection caused by Nocardia brasiliensis and Exophiala jeanselmei is reported in a liver transplant patient.


RESULTS
The cutaneous lesions were painful nodules which drained purulent material. They were located on the right lower limb, with lymphadenopathies in the groin.


CONCLUSIONS
The patient was treated with itraconazole (600 mg/day) plus trimethoprim (1600 mg/day)-sulfamethoxazole (320 mg/day) for 8 weeks, with complete remission of the lesions.
Parra
Isabel Hidalgo
IH
Dermatology Department, Italian Hospital, Buenos Aires, Argentina.
Galimberti
Ricardo
R
Galimberti
Gastón
G
Guanella
Barbara
B
Kowalczuk
Alicia
A
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D003881:Dermatomycoses / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D005093:Exophiala / Q000302:isolation & purification; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use; D016031:Liver Transplantation; D008205:Lymphangitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D009615:Nocardia / Q000302:isolation & purification; D009617:Nocardia Infections / Q000175:diagnosis* / Q000188:drug therapy; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D017192:Skin Diseases, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D017964:Itraconazole; D015662:Trimethoprim, Sulfamethoxazole Drug Combination